Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Silicon carbide (SiC) is an inorganic compound made up of silicon and carbon atoms in a 1:1 ratio, arranged in a tetrahedral lattice structure through strong covalent bonding. SiC exists in over 200 polytypes, primarily distinguished by varying stacking sequences of the silicon-carbon layers, with the cubic (β-SiC, 3C), hexagonal (4H-SiC, 6H-SiC), and rhombohedral forms being the most important industry-wise. It is renowned for its exceptional hardness (Mohs ~9-13, next to diamond and boron carbide), high thermal conductivity, chemical inertness, and significant resistance to high temperatures and abrasion. Applications include abrasives, refractory materials, heating elements, structural ceramics, and as a semiconductor material for high-power, high-temperature electronics. Silicon carbide is not a biological drug target or biomacromolecule, and it has no established role in drug discovery or medical therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Silicon carbide (SiC).